Style | Citing Format |
---|---|
MLA | Abedini M, et al.. "The Effect of Concentrated Pomegranate Juice Consumption on Risk Factors of Cardiovascular Diseases in Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial." Phytotherapy Research, vol. 35, no. 1, 2021, pp. 442-451. |
APA | Abedini M, Ghasemitehrani H, Tarrahi MJ, Amani R (2021). The Effect of Concentrated Pomegranate Juice Consumption on Risk Factors of Cardiovascular Diseases in Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial. Phytotherapy Research, 35(1), 442-451. |
Chicago | Abedini M, Ghasemitehrani H, Tarrahi MJ, Amani R. "The Effect of Concentrated Pomegranate Juice Consumption on Risk Factors of Cardiovascular Diseases in Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial." Phytotherapy Research 35, no. 1 (2021): 442-451. |
Harvard | Abedini M et al. (2021) 'The Effect of Concentrated Pomegranate Juice Consumption on Risk Factors of Cardiovascular Diseases in Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial', Phytotherapy Research, 35(1), pp. 442-451. |
Vancouver | Abedini M, Ghasemitehrani H, Tarrahi MJ, Amani R. The Effect of Concentrated Pomegranate Juice Consumption on Risk Factors of Cardiovascular Diseases in Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial. Phytotherapy Research. 2021;35(1):442-451. |
BibTex | @article{ author = {Abedini M and Ghasemitehrani H and Tarrahi MJ and Amani R}, title = {The Effect of Concentrated Pomegranate Juice Consumption on Risk Factors of Cardiovascular Diseases in Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial}, journal = {Phytotherapy Research}, volume = {35}, number = {1}, pages = {442-451}, year = {2021} } |
RIS | TY - JOUR AU - Abedini M AU - Ghasemitehrani H AU - Tarrahi MJ AU - Amani R TI - The Effect of Concentrated Pomegranate Juice Consumption on Risk Factors of Cardiovascular Diseases in Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial JO - Phytotherapy Research VL - 35 IS - 1 SP - 442 EP - 451 PY - 2021 ER - |